Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Interferon-Beta: Neutralizing Antibodies, Binding Antibodies, Pharmacokinetics and Pharmacodynamics, and Clinical Outcomes.
Disease mechanisms in MS: Neuronal network connectivity is altered in multiple sclerosis.
Intravenous immunoglobulin preparation attenuates neurological signs in rat experimental autoimmune neuritis with the suppression of macrophage inflammatory protein -1α expression.
Job placement interventions for people with multiple sclerosis.
Long-term effects of whole body cryostimulation on uric acid concentration in plasma of secondary progressive multiple sclerosis patients.
Validity of Minimal Clinically Important Difference Values for the Multiple Sclerosis Walking Scale-12?
Traumatic fatal cerebral hemorrhage in an old patient with a history of multiple sclerosis under dabigatran: a case report and review of the literature.
Glial cell biology in the Great Lakes region.
'Spinal amaurosis' (1841). On the early contribution of Edward Hocken to the concept of neuromyelitis optica.
Interleukin-12p40 in the spinal fluid as a biomarker for clinically isolated syndrome.
External memory aids for memory problems in people with multiple sclerosis: A systematic review.
Vitamin D and the central nervous system.
Circulating MicroRNAs: A Novel Class of Potential Biomarkers for Diagnosing and Prognosing Central Nervous System Diseases.
Takayasu arteritis associated with ulcerative colitis and optic neuritis: first case in Korea.
Optic neuritis: Experience from a south Indian demyelinating disease registry.
Primary progressive multiple sclerosis: progress and challenges.
Human adipose stromal/stem cells from obese donors show reduced efficacy in halting disease progression in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
Quantifying gait impairment using an instrumented treadmill in people with multiple sclerosis.
Sporadic Porphyria Cutanea Tarda in a Patient with Multiple Sclerosis Treated with Interferon Beta 1-a Therapy: A Case Report.
Adult-onset Krabbe disease presenting with an isolated form of peripheral neuropathy.
Further evidence for the neuroprotective role of oleanolic acid in a model of focal brain hypoxia in rats.
Cognitive and White Matter Tract Differences in MS and Diffuse Neuropsychiatric Systemic Lupus Erythematosus.
"Optic neuritis" that is neither.
White and gray matter damage in primary progressive MS: The chicken or the egg?
Validity and reliability of the FSS in Greek MS patients.
Pages
« first
‹ previous
…
459
460
461
462
463
464
465
466
467
…
next ›
last »